New biopsy technique aims to decode prostate cancer cell by cell
NCT ID NCT02313623
First seen Feb 16, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This study tested a new way to collect and analyze prostate cancer cells using MR-US image fusion targeted biopsy. Researchers grew cells from 600 men in the lab to study their unique protein and genetic profiles. The goal was to better predict how aggressive a person's prostate cancer might be. This was a research study, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yale University
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.